SonoScape Medical Corp
SZSE:300633
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SonoScape Medical Corp
SZSE:300633
|
CN |
|
Greif Inc
NYSE:GEF
|
US |
|
D
|
Dalian BIO-CHEM Co Ltd
SSE:603360
|
CN |
|
G
|
Gloster Ltd
BSE:542351
|
IN |
|
Tiangong International Co Ltd
HKEX:826
|
CN |
|
M
|
Mdundocom A/S
CSE:MDUNDO
|
DK |
|
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
CN |
|
C
|
China Fordoo Holdings Ltd
HKEX:2399
|
CN |
|
Sight Sciences Inc
NASDAQ:SGHT
|
US |
|
Forbes & Company Ltd
BSE:502865
|
IN |
|
B
|
Bank of Ireland Group PLC
ISEQ:BIRG
|
IE |
|
D
|
Discovery Ltd
JSE:DSY
|
ZA |
|
BGI Inc
OTC:BGRP
|
US |
|
Hospital Mater Dei SA
BOVESPA:MATD3
|
BR |
|
PYC Therapeutics Ltd
ASX:PYC
|
AU |
|
Wild Bunch AG
F:WBAH
|
DE |
|
Aktia Bank Abp
LSE:0QF8
|
FI |
|
Northland Power Inc
TSX:NPI
|
CA |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
Paymentus Holdings Inc
NYSE:PAY
|
US |
|
K
|
Kontrol Technologies Corp
NEO:KNR
|
CA |
|
A
|
Arthur J. Gallagher & Co.
SWB:GAH
|
US |
Wall Street
Price Targets
Price Targets Summary
SonoScape Medical Corp
According to Wall Street analysts, the average 1-year price target for
SonoScape Medical Corp
is 38.37 CNY
with a low forecast of 28.68 CNY and a high forecast of 46.25 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SonoScape Medical Corp's stock price target?
Price Target
38.37
CNY
According to Wall Street analysts, the average 1-year price target for
SonoScape Medical Corp
is 38.37 CNY
with a low forecast of 28.68 CNY and a high forecast of 46.25 CNY.
What is SonoScape Medical Corp's Revenue forecast?
Projected CAGR
14%
For the last 10 years the
compound annual growth rate for
SonoScape Medical Corp's revenue is
12%.
The projected
CAGR
for the next 4 years is
14%.
What is SonoScape Medical Corp's Operating Income forecast?
Projected CAGR
54%
For the last 10 years the
compound annual growth rate for
SonoScape Medical Corp's operating income is
1%.
The projected
CAGR
for the next 3 years is
54%.
What is SonoScape Medical Corp's Net Income forecast?
Projected CAGR
55%
For the last 10 years the
compound annual growth rate for
SonoScape Medical Corp's net income is
1%.
The projected
CAGR
for the next 3 years is
55%.
